Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of

M Šantak1, M Lang-Balija, J Ivancic-Jelecki

  • 1Institute of Immunology, Department for Research and Development, Zagreb, Croatia. msantak@imz.hr

Epidemiology and Infection
|September 8, 2012
PubMed

Insights

Mumps virus evolution, not genotype, reduces vaccine antibody effectiveness. Gradual viral changes decrease neutralization capacity, impacting mumps vaccine efficacy in vaccinated populations.

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • Mumps outbreaks occur in vaccinated individuals, with genotype G predominant.
  • Understanding viral evolution is crucial for vaccine effectiveness.

Purpose of the Study:

  • To assess the neutralization efficacy of vaccine-induced antibodies against contemporary mumps virus strains.
  • To identify factors contributing to reduced vaccine effectiveness.

Main Methods:

  • Guinea pig sera immunized with three mumps vaccine strains (L-Zagreb, Urabe AM9, JL5) were tested.
  • Neutralization assays were performed against seven mumps viruses (three vaccine, four wild-type strains from genotypes G, C, and D).
  • Amino acid sequence alignment was used to identify potential neutralization escape regions.

Main Results:

  • All tested sera neutralized all mumps virus strains, but with varying efficiency.
  • Neutralization efficiency decreased significantly with the temporal isolation of viruses.
  • Three novel regions (113-130, 375-403, 440-443) were identified as potentially involved in neutralization escape.

Conclusions:

  • Gradual antigenic drift in mumps viruses, rather than specific genotypes, reduces the efficacy of vaccine-induced antibodies.
  • Ongoing viral evolution necessitates continuous monitoring of mumps virus strains and vaccine performance.
  • Identified neutralization escape regions provide targets for future vaccine development and strain characterization.

Related Concept Videos

Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...